Atrion Corporation (ATRI)

Market Cap	678.81M
Revenue (ttm)	169.33M
Net Income (ttm)	19.41M
Shares Out	1.76M
EPS (ttm)	11.02
PE Ratio	35.00
Forward PE	n/a
Dividend	$8.80 (2.28%)
Ex-Dividend Date	Mar 14, 2024

Volume	25,379
Open	399.00
Previous Close	398.76
Day's Range	385.27 - 407.38
52-Week Range	274.98 - 670.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	May 6, 2024

About ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiova...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1944
• Employees: 712
• Stock Exchange: NASDAQ
• Ticker Symbol: ATRI

Financial Performance

In 2023, Atrion's revenue was $169.33 million, a decrease of -7.73% compared to the previous year's $183.51 million. Earnings were $19.41 million, a decrease of -44.55%.